Erdoğan Deniz

Erdoğan Deniz

Auto-generated profile, based on publicly available information

Erdoğan Deniz

Ankara Bilkent City Hospital, Department of Gastroenterology and Hepatology, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
MYMahmut Yüksel
Mahmut Yüksel
KKKenarli Kenarli
Kenarli Kenarli
FSFırathan Sarıaltın
Fırathan Sarıaltın
ESEmine Sena Sözen
Emine Sena Sözen
AAAHMET AKBAY
AHMET AKBAY
HKHASAN TANKUT KÖSEOĞLU
HASAN TANKUT KÖSEOĞLU
Background/Aims: Obesity is a growing global health challenge associated with increased morbidity and mortality. Intragastric balloon therapy has emerged as a minimally invasive alternative for weight management in patients unsuitable for bariatric surgery or as a bridging intervention. This study evaluates the efficacy, safety, and metabolic impacts of intragastric balloon therapy in a prospective cohort. Materials and Methods: A total of 65 patients underwent endoscopic intragastric balloon therapy between October 2023 and January 2025. Comprehensive baseline evaluations included body weight, body mass index, and computed tomography analysis of visceral and subcutaneous fat tissue thickness. Patients were followed up at 2 and 6 months post procedure. Statistical analysis was performed to assess weight loss, metabolic changes, and safety outcomes. Results: Of the initial cohort, 62 patients (mean age: 37.89 years; 75.4% female) completed the study. The median body weight decreased significantly from 104.5 kg pre procedure to 88 kg at 6 months (P < .001). Body mass index values similarly declined, with a mean reduction from 37.59 to 32.79 kg/m2 (P < .001). Significant decreases in subcutaneous and visceral fat tissue thickness were observed (P < .001 and P = .032, respectively). Only 1 patient (1.5%) required early balloon removal due to nausea, with no other major complications reported. Conclusion: Intragastric balloon therapy is an effective and safe intervention for short term weight loss, with significant reductions in adipose tissue. Further research is needed to evaluate its long-term efficacy and metabolic benefits. Cite this article as: Yüksel M, Kenarlı K, Sarıaltın F, et al. Six-month outcomes of endoscopic intragastric balloon therapy: A prospective single-center study. Turk J Gastroenterol. 2025;36(11):770-775.

1 January 2022 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
YPYavuz Emre Parlar
Yavuz Emre Parlar
HBhatice yasemin Balaban
hatice yasemin Balaban
UMUmit Yavuz Malkan
Umit Yavuz Malkan
EDErdogan Deniz
Erdogan Deniz
FUFatma Rukiye Uysal
Fatma Rukiye Uysal
D-penicillamine therapy is considered an effective and safe treatment for Wilson’s disease. Except for one experimental study, there has been no report in the literature about the development of disseminated intravascular coagulation (DIC) with the use of the drug. A 24-year-old female patient with Wilson’s disease, followed up with zinc and D-penicillamine treatment, was admitted to the emergency service because of oral mucosal bleeding and lethargy. Initial laboratory tests showed hemoglobin 7.1 g/dL (11.7-15.5), platelet 24×103 µL-1 (159-388), total bilirubin 18 mg/dL (0.3-1.2), direct bilirubin 9.8 mg/dL (0-0.2), INR >10 (0.8-1.2), aPTT 64.5 s (22.5-32), fibrinogen 23 mg/dL (180-350), and factor 8 26.4% (70-150). Melena, hematemesis, and hematochezia were not present, and no active bleeding focus was detected on endoscopic evaluation. Upon meeting the DIC criteria, the patient underwent plasma exchange four times for the treatment of acute-on-chronic liver failure. Haemocomplettan-P, cryoprecipitate replacements were made as a supportive treatment for DIC. As the clinical bleeding continued despite plasma exchanges and factor replacement treatment, D-penicillamine was switched to trientine (1250 mg/day). After this change, the mucosal bleeding stopped, and DIC parameters improved. We suggest that if hemorrhagic complications develop on D-penicillamine treatment, the possibility of DIC induced by D-penicillamine activating the fibrinolysis should also be considered.

3 November 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
AFAhmet Burak Fedai̇
Ahmet Burak Fedai̇
BÖBülent Ödemi̇ş
Bülent Ödemi̇ş
KKKenarli Kenarli
Kenarli Kenarli
GKGöktürk Karataş
Göktürk Karataş
MOMuhammed Emin Oktay
Muhammed Emin Oktay
NÜNAZMİ GÖKHAN ÜNVER
NAZMİ GÖKHAN ÜNVER
Biliary strictures following liver transplantation, iatrogenic biliary injury, or primary sclerosing cholangitis remain challenging clinical conditions. Al

30 December 2024 in Anatolian Journal of Emergency Medicine
Verified
Journal Article
Closed access
KKKenarli Kenarli
Kenarli Kenarli
NÜNAZMİ GÖKHAN ÜNVER
NAZMİ GÖKHAN ÜNVER
FSFırathan Sarıaltın
Fırathan Sarıaltın
AFAhmet Burak Fedai
Ahmet Burak Fedai
EDErdoğan Deniz
Erdoğan Deniz
MYMahmut Yüksel
Mahmut Yüksel
Aim: We aimed to determine the correlation between endoscopic and computed tomography (CT) grading scores in patients presenting after caustic ingestion and to evaluate their effectiveness in predicting the severity of lesions. Material and Methods: Patients aged 18 and older who presented to our emergency department due to caustic ingestion between 2019 and 2023 were included in the study. Clinical records of the patients were retrospectively analyzed. Results: A total of 57 patients (27 males, 47.4%; 30 females, 52.6%) were included in the study. The mean age of the patients was 41.6 (±17.0) years. CT findings and emergency endoscopic evaluation results at the time of emergency department presentation were compared. When the CT scores were compared with the Zargar classification, statistically significant similarities were found for both the esophagus and the stomach. Conclusion: This study suggests that CT evaluation in patients presenting with caustic ingestion may be as effective as emergency endoscopy. Additionally, for patients identified by CT as having a low likelihood of requiring an endoscopic intervention, treatment and follow-up may be feasible without performing emergency endoscopy.

20 February 2026 in Akademik Gastroenteroloji Dergisi
Verified
Journal Article
Closed access
KKKerem Kenarlı
Kerem Kenarlı
BÖBülent Ödemiş
Bülent Ödemiş
NÜNAZMİ GÖKHAN ÜNVER
NAZMİ GÖKHAN ÜNVER
EKEmir Tuğrul Keskin
Emir Tuğrul Keskin
AMAlper Macif
Alper Macif
EDErdoğan Deniz
Erdoğan Deniz
Background and Aims: Dominant biliary strictures are a clinically important complication in primary sclerosing cholangitis that often require endoscopic therapy. Although balloon dilation with or without short-term stenting is recommended, long-term real-world outcome data remain limited. Materials and Methods: We retrospectively evaluated consecutive primary sclerosing cholangitis patients who underwent endoscopic retrograde cholangiopancreatography for dominant strictures between 2011 and 2023 at a tertiary referral center. All procedures were performed by a single experienced endoscopist. Interventions included endoscopic balloon or bougie dilation with subsequent short-term biliary drainage. The primary endpoint was recurrence-free survival at 24 months; secondary endpoints included clinical and biochemical response, disease progression, and safety outcomes. Results: Total of 35 patients (mean age 42.0 ± 13.5 years; 68.6% male) underwent 138 endoscopic procedures, with a median of three interventions per patient. Dilation was performed in 94.3% of cases, and all patients received short-term stenting or nasobiliary drainage (median duration 15 days). At three months, 78.8% of patients were asymptomatic and 80.0% achieved a ≥ 20% reduction in alkaline phosphatase. The 24-month recurrence-free survival rate was 45.4%. The overall complication rate was 8.0% (including cholangitis, pancreatitis, and stent migration), with no procedure-related mortality. Conclusion: Endoscopic management -particularly balloon dilation with short-term drainage- appears to be a safe and effective strategy for dominant strictures in primary sclerosing cholangitis, offering substantial short-term clinical and biochemical improvement with an acceptable safety profile. Nevertheless, the high recurrence rate highlights the chronic relapsing nature of the disease and emphasizes the need for structured long-term surveillance.